Clinical Trial Update: A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa [Phase 3]

View source ↗

Summary

Phase 3 study evaluating physical activity and joint health in severe Hemophilia A patients aged 12 and older treated once weekly with efanesoctocog alfa; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Efanesoctocog alfa (efanesoctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A, Severe | Phase 3 | Status: ACTIVE_NOT_RECRUITING